Interaction of At1-Receptor Antagonists and Thiazolidindiones with the Atp-Binding Cassette Transporters P-Gp, Bcrp, Mrp1, and Mrp2

被引：0
|
作者：
Sauer, Alexandra [1 ]
Benndorf, Ralf [2 ]
Boeger, Rainer [2 ]
Haefeli, Walter Emil [1 ]
Weiss, Johanna [1 ]
机构：
[1] Univ Klinikum Heidelberg Innere Med VI, Klin Pharmakol & Pharmakoepidemiol, D-69120 Heidelberg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Inst Expt & Klin Pharmakol & Toxikol, D-20246 Hamburg, Germany
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2009年 / 104卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：519 / 519
页数：1
相关论文
共 50 条
  • [21] 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells
    Ranjbar, Sara
    Khonkarn, Ruttiros
    Moreno, Alexis
    Baubichon-Cortay, Helene
    Miri, Ramin
    Khoshneviszadeh, Mehdi
    Saso, Luciano
    Edraki, Najmeh
    Falson, Pierre
    Firuzi, Omidreza
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 362 : 136 - 149
  • [22] Multidrug Resistance Protein 1 (MRP1, ABCC1), a "Multitasking" ATP-binding Cassette (ABC) Transporter
    Cole, Susan P. C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (45) : 30880 - 30888
  • [23] Differential involvement of P-gp, MRP2 and BCRP on the absorption of CKD-602 and topotecan
    Li, Hong
    Kim, Dae-Duk
    Chung, Suk-Jae
    Shim, Chang-Koo
    DRUG METABOLISM REVIEWS, 2006, 38 : 75 - 76
  • [24] Arylhydrocarbon receptor-dependent regulation of the ABC transporters BCRP, MRP2 and P-gp in kidney tubules from killifish (Fundulus heteroclitus)
    Mahringer, A.
    Seymour, A.
    Miller, D. S.
    Fricker, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 9 - 9
  • [25] ABC drug transporters:: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2
    Kerb, R
    Hoffmeyer, S
    Brinkmann, U
    PHARMACOGENOMICS, 2001, 2 (01) : 51 - 64
  • [26] Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense
    Leslie, EM
    Deeley, RG
    Cole, SPC
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 204 (03) : 216 - 237
  • [27] Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats
    van Vliet, EA
    Redeker, S
    Aronica, E
    Edelbroek, PM
    Gorter, JA
    EPILEPSIA, 2005, 46 (10) : 1569 - 1580
  • [28] Penetration of AT1-receptor antagonists through the blood-brain barrier: Are transporter proteins such as MRP-2 and P-gp involved?
    Jacob, T.
    Schuster, S. O.
    Cascorbi, I
    Culman, J.
    Gohlke, P.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S29 - S29
  • [29] Interaction of Angiotensin Receptor Type 1 Blockers with ATP-binding Cassette Transporters
    Weiss, J.
    Sauer, A.
    Divac, N.
    Herzog, M.
    Schwedhelm, E.
    Boeger, R. H.
    Haefeli, W. E.
    Benndorf, R. A.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2010, 31 (2-3) : 150 - 161
  • [30] Cannabinoid Type 1 Receptor Antagonists Modulate Transport Activity of Multidrug Resistance-Associated Proteins MRP1, MRP2, MRP3, and MRP4
    Wittgen, Hanneke G. M.
    van den Heuvel, Jeroen J. M. W.
    van den Broek, Petra H. H.
    Dinter-Heidorn, Heike
    Koenderink, Jan B.
    Russel, Frans G. M.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (07) : 1294 - 1302
12345